Facilitating treatment with a new product for Severe Asthma

A Clarivate client wanted to help severe-asthma patients get onto a newly launched treatment faster. The program ran a compliant digital messaging campaign targeting both GPs and pharmacists in France, escalating under-treated severe-asthma patients through the care pathway toward the new product. The page states the initiative resulted in "350,000 fewer asthma attacks," reaching patients who had previously gone without specialist referral.

The customer is anonymised in Clarivate’s own case study — not withheld by us.

Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.